(Q38017477)

27 August 2017

Diabetes and cognitive dysfunction (English)

1 reference

27 August 2017

Rory J McCrimmon

1

0 references

Christopher M. Ryan

object named as

Christopher M Ryan

series ordinal

2

0 references

author name string

Brian M Frier

series ordinal

3

1 reference

PubMed ID

22683129

27 August 2017

language of work or name

English

0 references

publication date

9 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

379

1 reference

27 August 2017

9833

1 reference

27 August 2017

2291-2299

1 reference

Sugar and stroke: cerebrovascular disease and blood glucose control.

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

The effects of type 1 diabetes on cognitive performance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Diabetes, aging, and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Neurocognitive functioning in preschool-age children with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Diabetes and brain damage: more (or less) than meets the eye?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Evidence for Diabetic Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Single photon emission tomography (SPECT) study of regional cerebral blood flow in normoalbuminuric children and adolescents with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Semi-quantitative assessment of cerebral blood flow with 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Structural brain imaging in diabetes: a methodological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

High connectivity between reduced cortical thickness and disrupted white matter tracts in long-standing type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Recurrent severe hypoglycaemia and cognitive function in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Long-term effect of diabetes and its treatment on cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cognition and diabetes: a lifespan perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Type 2 diabetes and risk of cognitive impairment and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Risk of dementia in diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Impairment of visual evoked potentials: an early central manifestation of diabetic neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Neurophysiological evidence for altered higher brain functions in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cerebral function in a relatively young subset of NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Cerebral perfusion in relation to cognitive function and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Gray matter prefrontal changes in type 2 diabetes detected using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Brain imaging in patients with diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Hypoglycemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Central nervous system function in youth with type 1 diabetes 12 years after disease onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Alterations of Cerebral Metabolism in Patients with Diabetes Mellitus Studied by Proton Magnetic Resonance Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Insulin is a two-edged knife on the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Neuropsychological effects of sleep loss: implication for neuropsychologists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Neuropsychological deficits among patients with late-onset minor and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Effectiveness of cognitive rehabilitation following acquired brain injury: a meta-analytic re-examination of Cicerone et al.'s (2000, 2005) systematic reviews.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

Treatment of depression in diabetes: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960360-2

7 January 2021

10.1016/S0140-6736(12)60360-2

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22683129